DK1002092T3 - Mimotoper af hypervariabel region 1 af E2-glycoproteinet fra HCV og anvendelser deraf - Google Patents
Mimotoper af hypervariabel region 1 af E2-glycoproteinet fra HCV og anvendelser derafInfo
- Publication number
- DK1002092T3 DK1002092T3 DK99924978T DK99924978T DK1002092T3 DK 1002092 T3 DK1002092 T3 DK 1002092T3 DK 99924978 T DK99924978 T DK 99924978T DK 99924978 T DK99924978 T DK 99924978T DK 1002092 T3 DK1002092 T3 DK 1002092T3
- Authority
- DK
- Denmark
- Prior art keywords
- hcv
- mimotopes
- hypervariable region
- glycoprotein
- applications
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9810756.8A GB9810756D0 (en) | 1998-05-19 | 1998-05-19 | Mimotopes of hypervariable region 1 of the e2 glycoprotein of hcv and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1002092T3 true DK1002092T3 (da) | 2006-03-06 |
Family
ID=10832337
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK99924978T DK1002092T3 (da) | 1998-05-19 | 1999-05-14 | Mimotoper af hypervariabel region 1 af E2-glycoproteinet fra HCV og anvendelser deraf |
Country Status (13)
Country | Link |
---|---|
US (1) | US7034108B1 (da) |
EP (1) | EP1002092B1 (da) |
JP (1) | JP4593780B2 (da) |
KR (1) | KR20010022026A (da) |
CN (1) | CN1274387A (da) |
AT (1) | ATE308618T1 (da) |
AU (1) | AU766610B2 (da) |
CA (1) | CA2297408C (da) |
DE (1) | DE69928064T2 (da) |
DK (1) | DK1002092T3 (da) |
ES (1) | ES2251832T3 (da) |
GB (1) | GB9810756D0 (da) |
WO (1) | WO1999060132A1 (da) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2809402A1 (fr) * | 2000-05-26 | 2001-11-30 | Dev Des Antigenes Combinatoire | Bibliotheques peptidiques combinatoires convergentes et leur application a la vaccination contre le virus de l'hepatite c |
JP2004509846A (ja) * | 2000-06-02 | 2004-04-02 | メルク エンド カムパニー インコーポレーテッド | 肝炎c型ウイルスコンジュゲート |
AU2002222139A1 (en) * | 2000-12-09 | 2002-06-18 | Cambridge University Technical Services Limited | Hcv vaccines |
JP4475561B2 (ja) | 2001-10-11 | 2010-06-09 | メルク・シャープ・エンド・ドーム・コーポレイション | C型肝炎ウイルスワクチン |
EP2172552A3 (en) | 2001-10-11 | 2010-07-21 | Merck Sharp & Dohme Corp. | Recombinant nucleic acids comprising regions of AD6 |
CN1305898C (zh) * | 2003-08-22 | 2007-03-21 | 中国科学院上海生命科学研究院 | 丙型肝炎病毒被膜蛋白hvr1模拟多肽、其编码基因及用途 |
CA2610919C (en) | 2005-06-17 | 2013-09-10 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. | Hepatitis c virus nucleic acid vaccine |
EP2030628B1 (en) * | 2006-06-01 | 2012-08-15 | Yun Cheng | A peptide for preventing or treating liver damage and its derivant and the use |
AR061365A1 (es) * | 2006-06-13 | 2008-08-20 | Athenix Corp | Metodos para generar diversidad genetica mediante mutagenesis con permutaciones |
CA2671203C (en) | 2006-11-29 | 2015-02-10 | Athenix Corp. | Improved grg23 epsp synthases: compositions and methods of use |
CN110078800B (zh) * | 2019-04-24 | 2021-01-29 | 中国人民解放军第二军医大学 | 合成肽在制备防治肝炎病毒感染药物中的用途 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU638762B2 (en) | 1989-10-05 | 1993-07-08 | Optein Inc | Cell-free synthesis and isolation of novel genes and polypeptides |
GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
IT1270939B (it) | 1993-05-11 | 1997-05-26 | Angeletti P Ist Richerche Bio | Procedimento per la preparazione di immunogeni e reagenti diagnostici,e immunogeni e reagenti diagnostici cosi' ottenibili. |
DE69433160T2 (de) | 1993-05-12 | 2004-07-08 | Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville | Konserviertes Motiv der Hepatitis C Virus E2/NS1 Region |
WO1995011922A1 (en) | 1993-10-29 | 1995-05-04 | Affymax Technologies N.V. | In vitro peptide and antibody display libraries |
US5492807A (en) | 1993-11-19 | 1996-02-20 | Santi; Daniel V. | Method of obtaining diagnostic reagents, assays and therapeutics based on clinical manifestations of a disease |
US6110465A (en) * | 1995-06-07 | 2000-08-29 | The United States Of America As Represented By The Department Of Health And Human Services | Nucleotide and deduced amino acid sequences of hypervariable region 1 of the envelope 2 gene of isolates of hepatitis C virus and the use of reagents derived from these hypervariable sequences in diagnostic methods and vaccines |
JPH11124398A (ja) * | 1997-10-22 | 1999-05-11 | Japan Energy Corp | C型肝炎ウイルス由来の抗原ペプチドとそれを用いる抗体検査薬 |
-
1998
- 1998-05-19 GB GBGB9810756.8A patent/GB9810756D0/en not_active Ceased
-
1999
- 1999-05-14 AU AU41435/99A patent/AU766610B2/en not_active Ceased
- 1999-05-14 CN CN99801173A patent/CN1274387A/zh active Pending
- 1999-05-14 EP EP99924978A patent/EP1002092B1/en not_active Expired - Lifetime
- 1999-05-14 ES ES99924978T patent/ES2251832T3/es not_active Expired - Lifetime
- 1999-05-14 WO PCT/EP1999/003344 patent/WO1999060132A1/en active IP Right Grant
- 1999-05-14 JP JP2000549738A patent/JP4593780B2/ja not_active Expired - Fee Related
- 1999-05-14 US US09/463,098 patent/US7034108B1/en not_active Expired - Fee Related
- 1999-05-14 AT AT99924978T patent/ATE308618T1/de active
- 1999-05-14 DK DK99924978T patent/DK1002092T3/da active
- 1999-05-14 CA CA2297408A patent/CA2297408C/en not_active Expired - Fee Related
- 1999-05-14 DE DE69928064T patent/DE69928064T2/de not_active Expired - Lifetime
- 1999-05-14 KR KR1020007000594A patent/KR20010022026A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2002515249A (ja) | 2002-05-28 |
ATE308618T1 (de) | 2005-11-15 |
GB9810756D0 (en) | 1998-07-15 |
EP1002092A1 (en) | 2000-05-24 |
US7034108B1 (en) | 2006-04-25 |
CA2297408C (en) | 2011-06-21 |
CA2297408A1 (en) | 1999-11-25 |
EP1002092B1 (en) | 2005-11-02 |
JP4593780B2 (ja) | 2010-12-08 |
DE69928064D1 (de) | 2005-12-08 |
KR20010022026A (ko) | 2001-03-15 |
CN1274387A (zh) | 2000-11-22 |
WO1999060132A1 (en) | 1999-11-25 |
DE69928064T2 (de) | 2006-07-20 |
AU766610B2 (en) | 2003-10-16 |
AU4143599A (en) | 1999-12-06 |
ES2251832T3 (es) | 2006-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69232906D1 (de) | Detektion des Hepatis-C Virus. | |
NO934542D0 (no) | Hepatitt C virus (HCV) polypeptider | |
FI870447A (fi) | Htlv-iii-hoeljepeptider. | |
NZ237666A (en) | Hiv envelope (env) polypeptides, antibodies and compositions for treating aids | |
DK0754704T3 (da) | Syntetiske antigener til påvisning af antistoffer mod hepatitis c-virus | |
DK0698216T4 (da) | Fremgangsmåder til typebestemmelse af hepatitis-C-virus og anvendte reagenser heri | |
DK1002092T3 (da) | Mimotoper af hypervariabel region 1 af E2-glycoproteinet fra HCV og anvendelser deraf | |
NZ518999A (en) | Vaccine compositions | |
NO20051715L (no) | HCV assay | |
WO2001093804A3 (en) | Hepatitis c virus conjugates | |
EP0870830A3 (en) | Chimera hepatitis C virus antigen | |
DK0599913T3 (da) | Monoklonale antistoffer mod formodet hepatitis C-virus NS5-proteiner og anvendelsesmetoder af samme | |
GR970300022T1 (en) | Peptide capable of being recognised by antibodies recognising the C33 antigen of hepatitis C virus | |
IT1270941B (it) | Peptidi di hcv e loro usi. |